|
1
|
Wijdicks EF, Sheth KN, Carter BS, Greer
DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ,
Wintermark M, et al: Recommendations for the management of cerebral
and cerebellar infarction with swelling: A statement for healthcare
professionals from the American Heart Association/American Stroke
Association. Stroke. 45:1222–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gasche Y and Copin JC: Blood-brain barrier
pathophysiology and ischaemic brain oedema. Ann Fr Anesth Reanim.
22:312–319. 2003.In French. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sandoval KE and Witt KA: Blood-brain
barrier tight junction permeability and ischemic stroke. Neurobiol
Dis. 32:200–219. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nout YS, Mihai G, Tovar CA, Schmalbrock P,
Bresnahan JC and Beattie MS: Hypertonic saline attenuates cord
swelling and edema in experimental spinal cord injury: A study
utilizing magnetic resonance imaging. Crit Care Med. 37:2160–2166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeng HK, Wang QS, Deng YY, Jiang WQ, Fang
M, Chen CB and Jiang X: A comparative study on the efficacy of 10%
hypertonic saline and equal volume of 20% mannitol in the treatment
of experimentally induced cerebral edema in adult rats. BMC
Neurosci. 11:1532010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schwarz S, Georgiadis D, Aschoff A and
Schwab S: Effects of hypertonic (10%) saline in patients with
raised intracranial pressure after stroke. Stroke. 33:136–140.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeynalov E, Chen CH, Froehner SC, Adams
ME, Ottersen OP, Amiry-Moghaddam M and Bhardwaj A: The perivascular
pool of aquaporin-4 mediates the effect of osmotherapy in
postischemic cerebral edema. Crit Care Med. 36:2634–2640. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang LQ, Zhu GF, Deng YY, Jiang WQ, Fang
M, Chen CB, Cao W, Wen MY, Han YL and Zeng HK: Hypertonic saline
alleviates cerebral edema by inhibiting microglia-derived TNF-alpha
and IL-1beta-induced Na-K-Cl Cotransporter up-regulation. J
Neuroinflammation. 11:1022014. View Article : Google Scholar
|
|
9
|
Liu L, Fujimoto M, Kawakita F, Ichikawa N
and Suzuki H: Vascular endothelial growth factor in brain edema
formation after subarachnoid hemorrhage. Acta Neurochir Suppl.
121:173–177. 2016. View Article : Google Scholar
|
|
10
|
Bauer AT, Burgers HF, Rabie T and Marti
HH: Matrix metal-loproteinase-9 mediates hypoxia-induced vascular
leakage in the brain via tight junction rearrangement. J Cereb
Blood Flow Metab. 30:837–848. 2010. View Article : Google Scholar
|
|
11
|
Gerstner ER, Duda DG, di Tomaso E, Ryg PA,
Loeffler JS, Sorensen AG, Ivy P, Jain RK and Batchelor TT: VEGF
inhibitors in the treatment of cerebral edema in patients with
brain cancer. Nat Rev Clin Oncol. 6:229–236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayashi T, Abe K, Suzuki H and Itoyama Y:
Rapid induction of vascular endothelial growth factor gene
expression after transient middle cerebral artery occlusion in
rats. Stroke. 28:2039–2044. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greenberg DA and Jin K: Vascular
endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci.
70:1753–1761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chapouly C, Tadesse Argaw A, Horng S,
Castro K, Zhang J, Asp L, Loo H, Laitman BM, Mariani JN, Straus
Farber R, et al: Astrocytic TYMP and VEGFA drive blood-brain
barrier opening in inflammatory central nervous system lesions.
Brain. 138:1548–1567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Argaw AT, Asp L, Zhang J, Navrazhina K,
Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, et al:
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in
CNS inflammatory disease. J Clin Invest. 122:2454–2468. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cobbs CS, Chen J, Greenberg DA and Graham
SH: Vascular endothelial growth factor expression in transient
focal cerebral ischemia in the rat. Neurosci Lett. 249:79–82. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling-in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimotake J, Derugin N, Wendland M, Vexler
ZS and Ferriero DM: Vascular endothelial growth factor receptor-2
inhibition promotes cell death and limits endothelial cell
proliferation in a neonatal rodent model of stroke. Stroke.
41:343–349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bates DO and Harper SJ: Regulation of
vascular permeability by vascular endothelial growth factors.
Vascul Pharmacol. 39:225–237. 2002. View Article : Google Scholar
|
|
20
|
Fulton D, Gratton JP, McCabe TJ, Fontana
J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A and Sessa WC:
Regulation of endothelium-derived nitric oxide production by the
protein kinase Akt. Nature. 399:597–601. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luissint AC, Artus C, Glacial F,
Ganeshamoorthy K and Couraud PO: Tight junctions at the blood brain
barrier: Physiological architecture and disease-associated
dysregulation. Fluids Barriers CNS. 9:232012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiao H, Wang Z, Liu Y, Wang P and Xue Y:
Specific role of tight junction proteins claudin-5, occludin, and
ZO-1 of the blood-brain barrier in a focal cerebral ischemic
insult. J Mol Neurosci. 44:130–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang S, Xia R, Jiang Y, Wang L and Gao F:
Vascular endothelial growth factors enhance the permeability of the
mouse blood-brain barrier. PLoS One. 9:pp. e864072014, View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uyama O, Okamura N, Yanase M, Narita M,
Kawabata K and Sugita M: Quantitative evaluation of vascular
permeability in the gerbil brain after transient ischemia using
Evans blue fluorescence. J Cereb Blood Flow Metab. 8:282–284. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang LF, Li X, Gao YB, Wang SM, Zhao L,
Dong J, Yao BW, Xu XP, Chang GM, Zhou HM, et al: Activation of
VEGF/Flk-1-ERK pathway induced blood-brain barrier injury after
microwave exposure. Mol Neurobiol. 52:478–491. 2015. View Article : Google Scholar
|
|
27
|
Hawkins BT and Davis TP: The blood-brain
barrier/neurovascular unit in health and disease. Pharmacol Rev.
57:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anfuso CD, Lupo G, Romeo L, Giurdanella G,
Motta C, Pascale A, Tirolo C, Marchetti B and Alberghina M:
Endothelial cell-pericyte cocultures induce PLA-2 protein
expression through activation of PKCalpha and the MAPK/ERK cascade.
J Lipid Res. 48:782–793. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JH, Cui HS, Shin SK, Kim JM, Kim SY,
Lee JE and Koo BN: Effect of propofol post-treatment on blood-brain
barrier integrity and cerebral edema after transient cerebral
ischemia in rats. Neurochem Res. 38:2276–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chi OZ, Hunter C, Liu X and Weiss HR:
Effects of anti-VEGF antibody on blood-brain barrier disruption in
focal cerebral ischemia. Exp Neurol. 204:283–287. 2007. View Article : Google Scholar
|
|
31
|
Zhang ZG, Zhang L, Jiang Q, Zhang R,
Davies K, Powers C, Bruggen Nv and Chopp M: VEGF enhances
angiogenesis and promotes blood-brain barrier leakage in the
ischemic brain. J Clin Invest. 106:829–838. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lafuente JV, Argandona EG and Mitre B:
VEGFR-2 expression in brain injury: Its distribution related to
brain-blood barrier markers. J Neural Transm (Vienna). 113:487–496.
2006. View Article : Google Scholar
|
|
33
|
Vohra PK, Hoeppner LH, Sagar G, Dutta SK,
Misra S, Hubmayr RD and Mukhopadhyay D: Dopamine inhibits pulmonary
edema through the VEGF-VEGFR2 axis in a murine model of acute lung
injury. Am J Physiol Lung Cell Mol Physiol. 302:L185–L192. 2012.
View Article : Google Scholar :
|
|
34
|
Roe K, Orillo B and Verma S: West Nile
virus-induced cell adhesion molecules on human brain microvascular
endothelial cells regulate leukocyte adhesion and modulate
permeability of the in vitro blood-brain barrier model. PLoS One.
9:pp. e1025982014, View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma SC, Li Q, Peng JY, Zhouwen JL, Diao JF,
Niu JX, Wang X, Guan XD, Jia W and Jiang WG: Claudin-5 regulates
blood-brain barrier permeability by modifying brain microvascular
endothelial cell proliferation, migration, and adhesion to prevent
lung cancer metastasis. CNS Neurosci Ther. 23:947–960. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang L, Cao W, Deng Y, Zhu G, Han Y and
Zeng H: Hypertonic saline alleviates experimentally induced
cerebral oedema through suppression of vascular endothelial growth
factor and its receptor VEGFR2 expression in astrocytes. BMC
Neurosci. 17:642016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu L, Ye Z, Pan Y, Li X, Fu X, Zhang B, Li
Y, Lin W, Li X and Gao Q: Vascular endothelial growth factor
aggravates cerebral ischemia and reperfusion-induced
blood-brain-barrier disruption through regulating
LOC102640519/HOXC13/ZO-1 signaling. Exp Cell Res. 369:275–283.
2018. View Article : Google Scholar : PubMed/NCBI
|
